Clinical Trial Update: Immune Biomarkers of Residual Beta-cell Mass in Type 1 Diabetes [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study from Assistance Publique - Hôpitaux de Paris investigating immune biomarkers of residual beta-cell ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Type 1 Diabetes | NA | Status: COMPLETED